Getinge expands production capacity of DPTE-BetaBag® to the US
Getinge is introducing production of DPTE-BetaBag® at its existing manufacturing site in Merrimack, NH, in the US. With the expansion, Getinge expects to double the production capacity of DPTE-BetaBag® in order to meet the positive growth in the sterile transfer business, primarily driven by increased demand of vaccine production.
Getinge is producing the DPTE-BetaBag® in Vendôme, France, since 1998. Customer demand has increased during recent years and Getinge has decided to invest in its existing manufacturing site in Merrimack, US, to meet the demand. The Merrimack site will mirror the current production set-up in Vendôme to ensure highest product quality and meet key customer demands.
“With this expansion we will have a dual supply structure for DPTE-BetaBag®, which is important to meet customer request for supply contingency”, says Harald Castler, Executive Vice President Life Science at Getinge. “With the investment in Merrimack we are looking at double the installed production capacity of DPTE-BetaBag®”.
The investment at the manufacturing site in Merrimack, US, will result in approximately 100 new job opportunities as well as an inhouse training center to ensure efficient and qualitative onboarding. The first production release is planned for the latter part of 2021, following process and customer product validations.
The manufacturing site in Vendôme, France, will remain a center of excellence for DPTE-BetaBag® and govern product design and product quality globally.
Learn more about Getinge’s products on www.getinge.com.
Media contact:
Anna Appelqvist, Vice President Corporate Communications
Phone: +46 (0)10 335 5906
E-mail: anna.appelqvist@getinge.com
About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.
Tags:
